The methyltransferases METTL7A and METTL7B confer resistance of cancer cells to thiol-based histone deacetylate inhibitors (Mnase-Seq)
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 2 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Samples
- 2 samples
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase InhibitorsMolecular cancer therapeutics · 2024
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE217129_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA896983 and SRA study SRP405940. Searching any of these in the dataset finder brings you back here.
The sample list for this study is not cached yet. Press Load samples and it will be fetched from NCBI.
+ 2 more — browse all 2 samples with per-sample file links →
- GSE217128 The methyltransferases METTL7A and METTL7B confer resistance of cancer cells to thiol-based histone deacetylate inhibitors (ATAC-Seq) 8 samples shares mettl7a, mettl7b, methyltransferases, thiol-based, deacetylate, resistance, inhibitors
- GSE217130 The methyltransferases METTL7A and METTL7B confer resistance of cancer cells to thiol-based histone deacetylate inhibitors 22 samples shares mettl7a, mettl7b, methyltransferases, thiol-based, deacetylate, resistance, inhibitors
- GSE217127 The methyltransferases METTL7A and METTL7B confer resistance of cancer cells to thiol-based histone deacetylate inhibitors (RNA-Seq) 12 samples shares mettl7a, mettl7b, methyltransferases, thiol-based, deacetylate, resistance, inhibitors
- GSE242326 METTL7B is an essential epigenetic regulator of lineage specification in glioblastoma [ChIPseq] 32 samples shares mettl7b
- GSE243132 METTL7B is an essential epigenetic regulator of lineage specification in glioblastoma 73 samples shares mettl7b
- GSE242328 METTL7B is an essential epigenetic regulator of lineage specification in glioblastoma [RNAseq] 16 samples shares mettl7b
- GSE242966 METTL7B is an essential epigenetic regulator of lineage specification in glioblastoma [scRNAseq] 9 samples shares mettl7b
- GSE281811 Combined inhibition of histone methyltransferases EZH2 and DOT1L is an effective therapy for neuroblastoma 16 samples shares methyltransferases
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.